Verbal ability impairment in juvenile systemic lupus erythematosus
Comprometimento da habilidade verbal no lúpus eritematoso sistêmico juvenil
Santos, Maria Carolina dos
Okuda, Eunice Mitiko
Ronchezel, Marcos Vinicius [UNIFESP]
Leon, Elaine Pires
Trindade, Vilma dos Santos [UNIFESP]
Bastos, Wanda Alves
Sacchetti, Silvana Brasilia
Is part ofRevista Brasileira De Reumatologia
MetadataShow full item record
Introduction/Objective: Evaluate the frequency of verbal ability impairment and associated factors in patients with juvenile systemic lupus erythematosus (JSLE). Patients and Methods: Cross sectional study of 36 children and adolescents with JSLE of a group of 57 patients at the Clinic of Rheumatology, Department of Pediatrics and Medical Clinic of Santa Casa de Misericordia de Sao Paulo. At the time of diagnosis and study, we analyzed the following epidemiological features: clinical, socioeconomic, and educational level. Patients underwent cognitive and laboratory tests and we assessed disease activity (SLEDAI), cumulative damage (SLICC-DI), and treatment with corticosteroids. The patients underwent cognitive tests (Wechsler Intelligence Scales: WISC III and Waiss III), and the results were evaluated according to epidemiological, clinical, laboratory and treatment features. Results: The mean age at diagnosis was 11.2 +/- 2 years and at the time of the study the mean age was 15.4 +/- 4.7 years. There was predominance of women (89%) and of socioeconomic class C patients (61.1%). The cognitive impairment found in these patients was frequent (58.3%), affecting more often the verbal ability. We found association of verbal ability impairment with low socioeconomic status and cumulative damage (P < 0.05), but not with disease activity, presence of autoantibodies, and dose of corticosteroids (P > 0.05). Conclusions: Change in verbal ability is frequent in JSLE and is associated with socioeconomic status and cumulative damage, and should be suspected and investigated, particularly in pediatric patients to avoid quality of life impairment in adulthood. As it is not related with disease activity or presence of autoantibodies, it should always be assessed in the presence or absence of these factors. Likewise, the doses of corticosteroids should be independently evaluated.
CitationRevista Brasileira De Reumatologia. New York: Elsevier Science Inc, v. 50, n. 4, p. 362-374, 2010.
- EPM - Artigos